Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 2Active not recruiting 1

Sponsor Class

OTHER 7NIH 3NETWORK 3INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Genitourinary 5Gastrointestinal 5Thoracic 4Other hematologic neoplasm 3Breast 3Gynecologic 2CNS 2Sarcoma 1Plasma cell 1Other solid neoplasm 1Lymphoid 1Head & Neck 1Dermatologic 1Classical hematology 1

Conditions

Breast Neoplasms 3Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

Cyclophosphamide 80Paclitaxel 53Trastuzumab 41Tamoxifen 40Doxorubicin 39Specimen Handling 35Docetaxel 35Magnetic Resonance Spectroscopy 34Radiotherapy 33Taxes 30Fluorouracil 26Chemotherapy, Adjuvant 26Carboplatin 24Epirubicin 22Biopsy 22Filgrastim 21Neoadjuvant Therapy 19Methotrexate 19aldesleukin 17Peripheral Blood Stem Cell Transplantation 16Bevacizumab 14Anastrozole 14exemestane 13Lapatinib 13veliparib 12CMF regimen 12sargramostim 11Goserelin 11Fulvestrant 11Capecitabine 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NIH × Watchful Waiting × Breast × Clear all
NCT02954874 2026-06-03

Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

National Cancer Institute (NCI)

Phase 3 Active not recruiting
1,155 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00632047 2013-08-26

Early Detection of Breast Cancer and Cervical Cancer in Women in India

National Cancer Institute (NCI)

Phase 2 Unknown
151,538 enrolled
BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms

NCT01666171 2013-07-10

Studying Changes in Breast Density in Patients With Early-Stage Breast Cancer Treated With Metformin Hydrochloride or Placebo on CAN-NCIC-MA.32

National Cancer Institute (NCI)

Unknown
458 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡